EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for …

…, B Mazieres, E Martin-Mola, K Pavelka… - Annals of the …, 2003 - ard.bmj.com
Objectives: To update the EULAR recommendations for management of knee osteoarthritis (OA)
by an evidence based medicine and expert opinion approach. Methods: The literature …

The PREMIER study: a multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or …

…, AF Kavanaugh, SB Cohen, K Pavelka… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To compare the efficacy and safety of adalimumab plus methotrexate (MTX)
versus MTX monotherapy or adalimumab monotherapy in patients with early, aggressive …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

…, I McInnes, E Mysler, P Nash, K Pavelka… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international Task …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

…, TK Kvien, X Mariette, K Pavelka… - Annals of the …, 2014 - ard.bmj.com
In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

…, E Martin-Mola, I McInnes, K Pavelka… - Annals of the …, 2010 - ard.bmj.com
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind …

…, A Gough, J Kalden, M Malaise, EM Mola, K Pavelka… - The Lancet, 2004 - thelancet.com
Background Etanercept and methotrexate are effective in the treatment of rheumatoid arthritis
but no data exist on concurrent initiation or use of the combination compared with either …

EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis

…, CD Mallen, T Nava, S Oliver, K Pavelka… - Annals of the …, 2013 - ard.bmj.com
The objective was to develop evidence -based recommendations and a research and educational
agenda for the non-pharmacological management of hip and knee osteoarthritis (OA). …

Treatment of rheumatoid arthritis with recombinant human interleukin‐1 receptor antagonist

…, Z Domljan, P Emery, G Nuki, K Pavelka… - Arthritis & …, 1998 - Wiley Online Library
Objective To evaluate the efficacy and safety of interleukin‐1 receptor antagonist (IL‐1Ra)
in patients with rheumatoid arthritis (RA). Methods Patients with active and severe RA (…

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical …

…, B Mazieres, E Martin-Mola, K Pavelka… - Annals of the …, 2005 - ard.bmj.com
Objective: To develop evidence based recommendations for the management of hip
osteoarthritis (OA). Methods: The multidisciplinary guideline development group comprised 18 …

Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study

K Pavelká, J Gatterová, M Olejarová… - Archives of internal …, 2002 - jamanetwork.com
Background Conventional symptomatic treatments for osteoarthritis do not favorably affect
disease progression. The aim of this randomized, placebo-controlled trial was to determine …